Lingjing Jiang

Appearances

THE EFFICACY AND SAFETY OF GUSELKUMAB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 QUASAR INDUCTION STUDY
Date
May 9, 2023
BACKGROUND: Gut dysbiosis is associated with persistent multi-system symptoms following SARS-CoV-2 infection, or post-acute COVID-19 syndrome (PACS). We performed a randomised controlled trial to assess the effects of gut microbiome modulation on alleviation of PACS symptoms…
Presenter
Jessica Allegretti
Brigham and Women's Hospital
Speakers
Laurent Peyrin-Biroulet
Brian Feagan
Western University
Brian Bressler
Gary Lichtenstein
University of Pennsylvania
Kuan-Hsiang Huang
Matthew Germinaro
Nicole Shipitofsky
Lingjing Jiang
Hongyan Zhang
Tadakazu Hisamatsu
Julián Panés
Axel Dignass
Bruce Sands
David T. Rubin
University of Chicago Division of the Biological Sciences